Strides Pharma Science gets USFDA nod for generic anti-bacterial capsules

Strides Pharma Science on Wednesday said it has received approval from the US health regulator for its generic tetracycline hydrochloride capsules used for treatment of many bacterial infections.

The approval granted by the United States Food and Drug Administration (USFDA) to the company's wholly-owned subsidiary, Strides Pharma Global, Singapore, is for multiple strengths of tetracycline hydrochloride capsules of 250 mg and 500 mg, the company said in a statement.

The product is a generic version of Achromycin V Capsules, 250 mg and 500 mg, of Avet Pharmaceuticals (previously Heritage Pharmaceuticals), it added.

Citing IQVIA MAT data, the company said the US market for